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ABSTRACT:
Intermittent fasting (IF) can facilitate neurodegenerative, neuroadaptive and neuroprotective processes leading to
profound effects on cognition and dementias. The impact that IF has on the central nervous system is still not fully
known. Several factors come into likely effect including changes in energy metabolism, oxidative damage, insulin
sensitivity, inflammation, and functional changes related to various neurotransmitters and hormones. During IF
ketones are produced in large quantities and the brain consumes these for energy. The presence of ketone bodies
increases the expression of the genes for brain derived neurotrophic factor which has a powerful effect on dementia
and cognition. Brain derived neurotrophic factor (BDNF) in the hippocampus, the striatum, and cerebral cortex affects
learning capabilities and memory. This process is enhanced by IF. IF also has multiple effects on the endocrine
wellbeing, including control of hypertension, metabolic syndrome, insulin resistance and dyslipidemia. In ancient
times, fasting was a common practice but with recent cellular studies the beneficial effects on the brain of IF are being
truly proven. In a world of costly health care with an increase in neurological disorders, IF could be an effective therapy
that is multi targeted, self-controlled and cost free .Further research is required to question the effect of IF in the
long-term and whether pharmaceuticals can come up with safer medication options that imitate the effects of IF
without a drastic change in the eating patterns.
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INTRODUCTION:
The current living norms are such that most people
have excessive food accessibility with relatively
decreased physical activity. Intermittent fasting (IF)
implies an eating plan that switches between eating
and fasting on a regular pattern. It is not a diet in the
conventional sense but a very popular fitness ritual. Its
success more so relies on vast periods of complete
absence of diet and not what one intake. There are
many protocols in practice for intermittent fasting
including lean gains protocol and eat- stop-eat
protocol. In lean gains protocol subjects are allowed to
eat eight hours followed by sixteen hours fasting while
eat-stop-eat protocol allows fasting for twenty fours
once a week. Another protocol popular as 5;2 diet
allows subject to consume only 500 calories daily for
two days and normal eating for five days.1 Muslims fast
from dawn until dusk during one month in the year
-Ramadan. While Christians, Jews, Buddhists, and
Hindus have different traditions to their fating ritual.
There is ample evidence from history that fasting was
observed anciently by the greats like Hippocrates who
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believed in a pure water only fast as a method of
healing or Plato who fasted for better physical and
mental efficiency. Interestingly there is recent research
that claims intermittent fasting may affect cognition
and dementias like Alzheimer’s disease.
COGNITION AND DEMENTIA: DEFINITION AND BURDEN

Dementia is one of the most common neurological
diseases especially among elderly. Its presenting
features include functional disability with memory
changes and cognitive deficits. The American
Psychiatric Association’ fifth edition of the Diagnostic
and Statistical Manual of Mental Disorders (DSM 5)
states Dementia as a major neurocognitive disorder
(NCD) and mild cognitive impairment (MCI) as a mild
NCD. The DSM-5 details cognitive domains which may
be affected in both mild and major NCD including
executive function, learning and memory, language,
and perceptual motor functions. Current global
prevalence of dementia is around 50 Million with more
than half living in low income and middle-income
countries. This number is supposed to reach up to 66
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compared to cognitively normal controls.13

million by 2030 and up to 115 million by 2050.2
Alzheimer disease (AD) is the most common form of
dementia and may contribute to 70-80 % of cases.2 It
is a major cause of disability among elderly population.
Burden of care of dementia patients lies with family
and health care system. Dementia care expenditure
may be leading financial burden for many health care
systems in coming years. Lack of awareness leads to
increase care giver burden and financial resources.2

INTERMITTENT FASTING AND NEURODEGENERATION:
Neurogenesis in adult hippocampus and its
connections to prefrontal cortex are linked to learning
and memory.14 Mild stressors like exercise, enriched
environment, and restricted daily intake were shown to
increase new neuron formation corroborating the
association between cognition and neuroplasticity.
Underlying mechanisms contributing toward effects of
fasting may include reduction in oxidative stress,
neurotrophic signal enhancement, and improved
bioenergetics. Reduced dietary intake and lack of
available energy leads to a perceived cellular stress by
neurons which in turn result in increased production of
stress resistant response proteins.

CELLULAR EFFECTS OF INTERMITTENT FASTING:
There are several adaptive cellular responses due to IF.
After meals glucose is used for energy usually and fat is
stored as triglycerides in adipose tissue. During fasting
triglycerides are broken down to fatty acids and glycerol
and later converted to ketones by the liver. Oxidation of
fatty acids leads to ketone bodies formation. In low
glucose states, ketones become major energy source
for brain. Ketones levels rise after 12 hours of fasting
and remain elevated for 24-28 hours.3 4 Ketone bodies
are important signaling molecules with effects on cells
and organ functions.5 They regulate the expression of
many proteins and molecules including fibroblast
growth factor 21,nicotinamide adenine dinucleotide
(NAD) and peroxisome proliferator activated receptor
etc. with profound effects on systemic metabolism.6
Ketone bodies also stimulate expression of the gene for
brain derived neurotrophic factor.7 Brain derived
neurotrophic factor(BDNF) affects the learning and
memory. IF has proven to stimulate BDNF in the various
parts of brain. 8 A published article by a leading expert
suggested caloric restriction leads to decreased
production of oxygen free radicals. 9 Moreover IF
enhances GABAergic inhibitory neurotransmission
which can prevent excitotoxicity and seizures seen in
around 10 percent patients with dementia.10 Dietary
changes may lead to changes in insulin sensitivity. 11

Several mechanisms are responsible for synthesis of
neurotropic factors especially brain derived neurotropic
factor and anti-oxidative enzymes. These include
peroxisome proliferator-activated receptors (PPARs),
insulin-like fork head box O (FOXO) signaling factors and
sirtuins (SIRTs). 26 Data from animal studies suggest
anti amyloidogenic activity in rodent brains is
maintained by increased generation of active A
disintegrin and metalloproteinase 10 (ADAM10)
proteins secondary to higher levels of SIRTI1. 15
This increased level of active ADAM10 not only reduces
Aβ but also can lead to reduction in Tau pathology and
increased hippocampal neurogenesis. Alternate day
fasting and daily caloric restriction reverses the adverse
effects of obesity, diabetes and neuro inflammation on
spatial learning and memory.
The underlying
mechanism in intermittent fasting is metabolic
switching in which metabolism is switched from glucose
to ketones. This mode of metabolism is main driver of
health benefits observed in some clinical and
pre-clinical studies.

BRAIN-DERIVED NEUROTROPHIC FACTOR
(BDNF) IN FASTING:

ANIMAL STUDIES:
Intermittent fasting may enhance many cognitive
domains including working memory, special memory,
and associative memory. 16 Studies have demonstrated
that short-term and medium-term intermittent fasting
could have a neuroprotective effect by decreasing
amyloid-β (Aβ) peptide aggregates and microglia
activation. Studies have shown that , rats and mice
maintained on an intermittent fasting routine exhibit
less neuronal dysfunction and degeneration. 17 nother
study looking at a rat model of menopause and
Alzheimer’s disease demonstrated that intermittent
fasting may prevent some of the metabolic pathologies
associated with

It has been shown in research studies that intermittent
fasting can increase BDNF expression in temporal lobes
especially hippocampus. BDNF is a neurotrophin with
multidimensional effects including plasticity and survival.
It may affect neurogenesis stimulate neuron survival.
Neurodegenerative disease for example Alzheimer’s
disease and Parkinsons Disease demonstrate decreased
BDNF levels. In healthy volunteers, mean plasma BDNF
levels were found to be approximately 92.5 pg./ml
(8.0–927.0 pg./ml).12 A recent study measured CSF
concentration of BDNF, Aβ42 and total tau in patients
with Alzheimer’s disease and mild cognitive impairment
and compared to cognitively normal subjects. Study
showed BDNF levels were lower in patients with AD as
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menopause and protect against age-related memory
decline.18
HUMAN STUDIES AND META ANALYSIS:
A small study of fifty healthy subjects divided into three
groups (controls; 30% caloric restriction and 20%
increase in fat intake) for three months demonstrated a
significant increase in verbal memory scores after caloric
restriction. These scores correlated with high levels of
CRP and decreased fasting plasma insulin levels. 19 Effect
of intentional and substantial weight loss on cognitive
function has been a topic of many research studies with
assessment of cognitive function using validated tools
before and after weight loss. A meta-analysis of these
studies showed heterogenous outcome with modest and
significant effect of weight loss on cognitive function. A
significant association between weight loss and
improvement in attention span and executive function
was also reported. 20 A recent study from Canada showed
that 2 years of caloric restriction in non-obese healthy
adults led to a significant improvement in in working
memory.21 Epidemiological data suggests that excessive
energy intake in midlife increases the risks of stroke and
neurodegenerative diseases.22 No clear consensus exists
to prove a beneficial effect of fasting in the adolescent
age. Some studies have also shown no impact or
negative impact on school performance and cognition
after short-term fasting. 23 Also at school going age a
lot
of confounders like socioeconomic
status,
psychopathological conditions, parents’ education, and
attitudes towards school would be difficult to take into
perspective. IF improves insulin sensitivity, and thus
prevents obesity. Six short term studies involving obese
or overweight adults have shown that IF is as effective for
weight loss as standard diets.24
FUTURE RESEARCH:
In a world of costly health care with increasing
neurological disorders, IF could be an effective beneficial
therapy that is multi targeted, self-controlled and cost
free. Detailed, unified research studies are needed to
investigate the possible implications of IF in the
long-term. Also, the possible implications of IF for people
who are within the normal body mass index Further
research is needed at the pharmaceutical level for safer
medication options that imitate the effects of IF without
a drastic change in the eating patterns as long-term
dietary and fluid restriction may have led to poor
performance and non-sustained attention. An important
research question would be to see the temporal effects
on cognition as this may not be seen immediately and
may have a more lasting impact. Physicians should
provide adequate information and support to patients
opting for IF as its implications may have considerable

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

36

adverse effects such as irritability and reduced
concentration especially in the beginning despite of
evidence for health benefits.
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